截至5月22日24时新型冠状病毒肺炎疫情全新情况,本土病例1例

2021-05-23 国家卫生健康委员会 国家卫生健康委员会

5月22日0—24时,31个省(自治区、直辖市)和新疆生产建设兵团报告新增确诊病例19例,其中境外输入病例18例(上海4例,四川4例,广东3例,福建2例,北京1例,天津1例,辽宁1例,浙江

5220—24时,31个省(自治区、直辖市)和新疆生产建设兵团报告新增确诊病例19例,其中境外输入病例18例(上海4例,四川4例,广东3例,福建2例,北京1例,天津1例,辽宁1例,浙江1例,云南1例),本土病例1例(在安徽);无新增死亡病例;无新增疑似病例。

当日新增治愈出院病例5例,解除医学观察的密切接触者1413人,重症病例较前一日减少1例。

境外输入现有确诊病例283例(其中重症病例3例),现有疑似病例1例。累计确诊病例5952例,累计治愈出院病例5669例,无死亡病例。

截至52224时,据31个省(自治区、直辖市)和新疆生产建设兵团报告,现有确诊病例315例(其中重症病例3例),累计治愈出院病例86022例,累计死亡病例4636例,累计报告确诊病例90973例,现有疑似病例2例。累计追踪到密切接触者1019372人,尚在医学观察的密切接触者6473人。

31个省(自治区、直辖市)和新疆生产建设兵团报告新增无症状感染25例,其中境外输入24例,本土1例(在广东);当日转为确诊病例6例(均为境外输入);当日解除医学观察13例(均为境外输入);尚在医学观察的无症状感染者376例(境外输入354例)。

累计收到港澳台地区通报确诊病例15742例。其中,香港特别行政区11830例(出院11550例,死亡210例),澳门特别行政区50例(出院49例),台湾地区3862例(出院1133例,死亡17例)。

信息来自国家卫生健康委员会官方网站

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1824516, encodeId=986318245165d, content=<a href='/topic/show?id=3a2d5819285' target=_blank style='color:#2F92EE;'>#新型冠状病毒肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58192, encryptionId=3a2d5819285, topicName=新型冠状病毒肺炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Thu Feb 17 22:07:08 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603791, encodeId=90ed1603e91ff, content=<a href='/topic/show?id=adc530923b2' target=_blank style='color:#2F92EE;'>#冠状病毒肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30923, encryptionId=adc530923b2, topicName=冠状病毒肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebae19082325, createdName=HNYYM, createdTime=Tue May 25 06:07:08 CST 2021, time=2021-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967984, encodeId=2cd396e98478, content=天有人间, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc514711487, createdName=441964562, createdTime=Sun May 23 19:25:19 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967963, encodeId=464996e96311, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210523/142a30f37658408183d8809217599398/c57fe41ab3e24013b050a573948c3b02.jpg, createdBy=45db5246795, createdName=147d1c98m12暂无昵称, createdTime=Sun May 23 17:24:33 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967953, encodeId=d8ef96e95314, content=好好学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun May 23 17:05:04 CST 2021, time=2021-05-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1824516, encodeId=986318245165d, content=<a href='/topic/show?id=3a2d5819285' target=_blank style='color:#2F92EE;'>#新型冠状病毒肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58192, encryptionId=3a2d5819285, topicName=新型冠状病毒肺炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Thu Feb 17 22:07:08 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603791, encodeId=90ed1603e91ff, content=<a href='/topic/show?id=adc530923b2' target=_blank style='color:#2F92EE;'>#冠状病毒肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30923, encryptionId=adc530923b2, topicName=冠状病毒肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebae19082325, createdName=HNYYM, createdTime=Tue May 25 06:07:08 CST 2021, time=2021-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967984, encodeId=2cd396e98478, content=天有人间, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc514711487, createdName=441964562, createdTime=Sun May 23 19:25:19 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967963, encodeId=464996e96311, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210523/142a30f37658408183d8809217599398/c57fe41ab3e24013b050a573948c3b02.jpg, createdBy=45db5246795, createdName=147d1c98m12暂无昵称, createdTime=Sun May 23 17:24:33 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967953, encodeId=d8ef96e95314, content=好好学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun May 23 17:05:04 CST 2021, time=2021-05-23, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1824516, encodeId=986318245165d, content=<a href='/topic/show?id=3a2d5819285' target=_blank style='color:#2F92EE;'>#新型冠状病毒肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58192, encryptionId=3a2d5819285, topicName=新型冠状病毒肺炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Thu Feb 17 22:07:08 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603791, encodeId=90ed1603e91ff, content=<a href='/topic/show?id=adc530923b2' target=_blank style='color:#2F92EE;'>#冠状病毒肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30923, encryptionId=adc530923b2, topicName=冠状病毒肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebae19082325, createdName=HNYYM, createdTime=Tue May 25 06:07:08 CST 2021, time=2021-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967984, encodeId=2cd396e98478, content=天有人间, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc514711487, createdName=441964562, createdTime=Sun May 23 19:25:19 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967963, encodeId=464996e96311, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210523/142a30f37658408183d8809217599398/c57fe41ab3e24013b050a573948c3b02.jpg, createdBy=45db5246795, createdName=147d1c98m12暂无昵称, createdTime=Sun May 23 17:24:33 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967953, encodeId=d8ef96e95314, content=好好学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun May 23 17:05:04 CST 2021, time=2021-05-23, status=1, ipAttribution=)]
    2021-05-23 441964562

    天有人间

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1824516, encodeId=986318245165d, content=<a href='/topic/show?id=3a2d5819285' target=_blank style='color:#2F92EE;'>#新型冠状病毒肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58192, encryptionId=3a2d5819285, topicName=新型冠状病毒肺炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Thu Feb 17 22:07:08 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603791, encodeId=90ed1603e91ff, content=<a href='/topic/show?id=adc530923b2' target=_blank style='color:#2F92EE;'>#冠状病毒肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30923, encryptionId=adc530923b2, topicName=冠状病毒肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebae19082325, createdName=HNYYM, createdTime=Tue May 25 06:07:08 CST 2021, time=2021-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967984, encodeId=2cd396e98478, content=天有人间, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc514711487, createdName=441964562, createdTime=Sun May 23 19:25:19 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967963, encodeId=464996e96311, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210523/142a30f37658408183d8809217599398/c57fe41ab3e24013b050a573948c3b02.jpg, createdBy=45db5246795, createdName=147d1c98m12暂无昵称, createdTime=Sun May 23 17:24:33 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967953, encodeId=d8ef96e95314, content=好好学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun May 23 17:05:04 CST 2021, time=2021-05-23, status=1, ipAttribution=)]
    2021-05-23 147d1c98m12暂无昵称

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1824516, encodeId=986318245165d, content=<a href='/topic/show?id=3a2d5819285' target=_blank style='color:#2F92EE;'>#新型冠状病毒肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58192, encryptionId=3a2d5819285, topicName=新型冠状病毒肺炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Thu Feb 17 22:07:08 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603791, encodeId=90ed1603e91ff, content=<a href='/topic/show?id=adc530923b2' target=_blank style='color:#2F92EE;'>#冠状病毒肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30923, encryptionId=adc530923b2, topicName=冠状病毒肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebae19082325, createdName=HNYYM, createdTime=Tue May 25 06:07:08 CST 2021, time=2021-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967984, encodeId=2cd396e98478, content=天有人间, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc514711487, createdName=441964562, createdTime=Sun May 23 19:25:19 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967963, encodeId=464996e96311, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210523/142a30f37658408183d8809217599398/c57fe41ab3e24013b050a573948c3b02.jpg, createdBy=45db5246795, createdName=147d1c98m12暂无昵称, createdTime=Sun May 23 17:24:33 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967953, encodeId=d8ef96e95314, content=好好学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun May 23 17:05:04 CST 2021, time=2021-05-23, status=1, ipAttribution=)]
    2021-05-23 jyzxjiangqin

    好好学习!

    0

相关资讯

Clin Gastroenterology H: COVID-19感染患者住院期间严重肝损伤不影响死亡率

新冠肺炎病毒-SARS-CoV-2的作用靶点是血管紧张素转换酶2受体(ACE-2),在这些受体似乎主要在胆管细胞中表达。

Lancet:非洲新冠肺炎重症患者死亡率近50%

与其他地区相比,非洲新冠肺炎重症患者的死亡率较高,重症医疗资源匮乏、HIV、糖尿病、慢性肝肾疾病以及入院时器官功能障碍的严重程度均与非洲新冠肺炎重症患者死亡率较高相关。

2021年5月23日全球新冠肺炎(COVID-19)疫情简报,日新增55.8万,全球疫情此起彼伏,使控制难度加大

Worldometers世界实时统计数据显示,截至北京时间2021年5月23日7时01分,全球累计确诊新冠肺炎(COVID-19)病例超过16702万例,新增558,054例,达到167,023,69

2021年5月20日全球新冠肺炎(COVID-19)疫情简报,日新增64.2万,新冠对人类影响可能持续数十年

Worldometers世界实时统计数据显示,截至北京时间2021年5月20日7时01分,全球累计确诊新冠肺炎(COVID-19)病例超过16552万例,新增641,506例,达到165,527,07

印度疫情失控背后:各国抗疫效果缘何参差不齐

近期,印度疫情迅速恶化,累计确诊已超3300万,死亡病例超27万,引起了全球的关注。同时也促使我们对世界各国应对疫情的治理模式进行总结与思考。

Eur Arch Otorhinolaryngol:过敏性鼻炎如何影响COVID-19的严重程度?

2019年12月,中国武汉市出现导致急性呼吸窘迫综合症(ARDS)的SARS-CoV-2,并成为一种迅速蔓延的大流行病。2020年2月11日,世界卫生组织(WHO)命名由这种新型冠状病毒导致的疾病为2